In a firm stance on Jan. 16, 2026, the Department of Justice argued that two U.S. representatives should not be permitted to intervene in Ghislaine Maxwell’s criminal case to push for the release of Jeffrey Epstein-related documents. The objection was detailed in a letter from Manhattan.
The DOJ contends that Reps. Ro Khanna, D-Calif., and Thomas Massie, R-Ky., lack standing to join as amici curiae in Maxwell’s case before U.S. District Judge Paul Engelmayer, asserting the matter is concluded and unrelated to their request for Epstein files. This follows the lawmakers’ recent motion to intervene.
The issue has sparked debate over the boundaries of congressional involvement in judicial matters. Critics question whether such interventions overstep legal norms and undermine the separation of powers critical to our system.
Courthouse News reports that on Friday, DOJ officials submitted a six-page letter to Judge Engelmayer, overseeing Maxwell’s case, arguing against the lawmakers’ role as “friends of the court.” They claim the representatives are pursuing personal interests rather than fitting within the defined amici framework.
U.S. Attorney Jay Clayton of the Southern District of New York emphasized that Khanna and Massie fail to show a concrete injury to justify standing. Their request to appoint a special master for document release, per DOJ, exceeds proper bounds.
Khanna and Massie, who co-led the Epstein Files Transparency Act passed late last year, demanded full disclosure of decades of investigative materials by Dec. 19, 2025. While thousands of documents are out, millions await redaction review, per DOJ statements.
Massie stated last week that the DOJ is “egregiously violating” the act by missing the deadline. This accusation underscores the lawmakers’ urgency in seeking court involvement to expedite the process.
Such claims of noncompliance raise valid concerns, yet one must wonder if injecting congressional oversight into a settled criminal case is the proper remedy. Under President Donald Trump’s administration, federal agencies deserve clear jurisdictional respect, not political overreach.
Clayton asserted, “This is a criminal case, with two parties — the government and defendant Ghislaine Maxwell — that is long since over.” He noted Maxwell’s judgment was finalized when the Supreme Court denied her release bid in October 2025.
This firm position highlights a core legal principle: closed cases shouldn’t be reopened for unrelated agendas. It’s a subtle irony that lawmakers championing transparency seem to blur the lines of judicial finality.
Khanna countered to Courthouse News, saying, “We are not seeking to relitigate Maxwell’s criminal case; rather, we are informing the court of serious misconduct by the Department of Justice that requires a remedy.” He stressed DOJ’s failure to meet the Dec. 19 deadline with victim protections.
Khanna’s argument suggests a noble intent to protect public interest, yet it sidesteps the DOJ’s point on standing. If every missed deadline warranted court intervention by Congress, the judiciary could become a political battleground under President Trump’s watch.
Renewed public interest in Epstein’s crimes, fueled by President Trump’s past ties resurfacing after the 2024 election, adds complexity. Trump has consistently dismissed inquiries about their association, a sensitive topic amid ongoing document reviews.
The workload from reviewing Epstein files may strain other prosecutions, as a Manhattan judge recently redirected staff to a major case involving three real-estate brothers accused of serious sex crimes. Maxwell, convicted in 2021, remains incarcerated, representing herself amid pardon rumors.
